Three Biotech Stocks To Buy Now: ABBV, BLUE, GILD
February 04, 2016 at 02:51 AM EST
The biotech sector is down over 20% YTD and has been in a bear market since September 2015 despite a Q4 rally. Unlike market trends in 2015 the biotech downdraft has coincided with negative macro news-flow and even correlation with crude prices.
